Jane Street
KALV

Jane Street’s KalVista Pharmaceuticals KALV Stock Holding History

Jane Street’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,608
Closed -$509K – 12308
2025
Q4 		$510K Sell
31,608
-5,055
-14% -$66.9K ﹤0.01% 7642
2025
Q3 		$447K Sell
36,663
-18,247
-33% -$252K ﹤0.01% 8099
2025
Q2 		$621K Buy
+54,910
New +$671K ﹤0.01% 6526
2025
Q1 		– Sell
-69,397
Closed -$708K – 10049
2024
Q4 		$588K Buy
69,397
+48,889
+238% +$506K ﹤0.01% 6437
2024
Q3 		$237K Sell
20,508
-16,505
-45% -$208K ﹤0.01% 8395
2024
Q2 		$436K Sell
37,013
-307,436
-89% -$3.59M ﹤0.01% 7236
2024
Q1 		$4.09M Buy
344,449
+306,932
+818% +$4.09M ﹤0.01% 2936
2023
Q4 		$460K Buy
37,517
+4,833
+15% +$44K ﹤0.01% 6902
2023
Q3 		$315K Buy
+32,684
New +$334K ﹤0.01% 6993
2023
Q1 		– Sell
-15,498
Closed -$105K – 9478
2022
Q4 		$105K Buy
+15,498
New +$83K ﹤0.01% 8062
2021
Q4 		– Sell
-19,797
Closed -$345K – 10473
2021
Q3 		$345K Buy
19,797
+7,618
+63% +$154K ﹤0.01% 7924
2021
Q2 		$292K Buy
+12,179
New +$319K ﹤0.01% 8186

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street's KALV Position: Q1 2026 in Review

Jane Street sold out of KalVista Pharmaceuticals (KALV) in Q1 2026, closing a stake of 31,608 shares — an estimated $509K sold.

Jane Street first reported a position in KALV in Q2 2021 and held it in 12 quarters. The position peaked at $4.09M in Q1 2024. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Jane Street reported no remaining KalVista Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 31,608 KalVista Pharmaceuticals shares in Q1 2026, an estimated $509K.
  • Jane Street first reported a position in KalVista Pharmaceuticals in Q2 2021 and held it in 12 quarters.
  • Jane Street's KalVista Pharmaceuticals position peaked at $4.09M in Q1 2024.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.